Hargreaves RJ - Search Results

1

Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs.

Longmore J, Hill RG, Hargreaves RJ. Longmore J, et al. Among authors: hargreaves rj. Can J Physiol Pharmacol. 1997 Jun;75(6):612-21. doi: 10.1139/cjpp-75-6-612. Can J Physiol Pharmacol. 1997. PMID: 9276138 Review.

2

The non-peptide neurokinin1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats.

Shepheard SL, Williamson DJ, Hill RG, Hargreaves RJ. Shepheard SL, et al. Among authors: hargreaves rj. Br J Pharmacol. 1993 Jan;108(1):11-2. doi: 10.1111/j.1476-5381.1993.tb13432.x. Br J Pharmacol. 1993. PMID: 7679023 Free PMC article.

3

Effect of RP 67580, a non-peptide neurokinin1 receptor antagonist, on facilitation of a nociceptive spinal flexion reflex in the rat.

Laird JM, Hargreaves RJ, Hill RG. Laird JM, et al. Among authors: hargreaves rj. Br J Pharmacol. 1993 Jul;109(3):713-8. doi: 10.1111/j.1476-5381.1993.tb13632.x. Br J Pharmacol. 1993. PMID: 8395296 Free PMC article.

4

Effects of a partial agonist and a full antagonist acting at the glycine site of the NMDA receptor on inflammation-induced mechanical hyperalgesia in rats.

Laird JM, Mason GS, Webb J, Hill RG, Hargreaves RJ. Laird JM, et al. Among authors: hargreaves rj. Br J Pharmacol. 1996 Apr;117(7):1487-92. doi: 10.1111/j.1476-5381.1996.tb15311.x. Br J Pharmacol. 1996. PMID: 8730744 Free PMC article.

5

In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists.

Rupniak NM, Tattersall FD, Williams AR, Rycroft W, Carlson EJ, Cascieri MA, Sadowski S, Ber E, Hale JJ, Mills SG, MacCoss M, Seward E, Huscroft I, Owen S, Swain CJ, Hill RG, Hargreaves RJ. Rupniak NM, et al. Among authors: hargreaves rj. Eur J Pharmacol. 1997 May 20;326(2-3):201-9. doi: 10.1016/s0014-2999(97)85415-5. Eur J Pharmacol. 1997. PMID: 9196273

6

Rizatriptan has central antinociceptive effects against durally evoked responses.

Cumberbatch MJ, Hill RG, Hargreaves RJ. Cumberbatch MJ, et al. Among authors: hargreaves rj. Eur J Pharmacol. 1997 Jun 5;328(1):37-40. doi: 10.1016/s0014-2999(97)83024-5. Eur J Pharmacol. 1997. PMID: 9203565

7

Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat.

Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL. Williamson DJ, et al. Among authors: hargreaves rj. Cephalalgia. 1997 Jun;17(4):518-24. doi: 10.1046/j.1468-2982.1997.1704518.x. Cephalalgia. 1997. PMID: 9209773

8

The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats.

Cumberbatch MJ, Hill RG, Hargreaves RJ. Cumberbatch MJ, et al. Among authors: hargreaves rj. Eur J Pharmacol. 1998 Nov 27;362(1):43-6. doi: 10.1016/s0014-2999(98)00764-x. Eur J Pharmacol. 1998. PMID: 9865528

9

Competitive as well as uncompetitive N-methyl-D-aspartate receptor antagonists affect cortical neuronal morphology and cerebral glucose metabolism.

Hargreaves RJ, Rigby M, Smith D, Hill RG, Iversen LL. Hargreaves RJ, et al. Neurochem Res. 1993 Dec;18(12):1263-9. doi: 10.1007/BF00975046. Neurochem Res. 1993. PMID: 7903796

10

Neuroprotective NMDA antagonists: the controversy over their potential for adverse effects on cortical neuronal morphology.

Hargreaves RJ, Hill RG, Iversen LL. Hargreaves RJ, et al. Acta Neurochir Suppl (Wien). 1994;60:15-9. doi: 10.1007/978-3-7091-9334-1_4. Acta Neurochir Suppl (Wien). 1994. PMID: 7976530 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters